miRNA Details
miRNA General Information | |||||
---|---|---|---|---|---|
miRNA Mature ID | hsa-miR-129-1-3p | ||||
miRNA Stemloop AC | MI0000252 | ||||
miRNA Stemloop ID | hsa-mir-129-1 | ||||
Sequence | aagcccuuaccccaaaaaguau | ||||
TTD Target(s) Regulated by This miRNA | Glycogen synthase kinase-3 beta (GSK-3B) | Clinical trial Target | Target Info | [1] | |
Aurora kinase A (AURKA) | Clinical trial Target | Target Info | [2] | ||
Programmed cell death protein 2 (PD-2) | Clinical trial Target | Target Info | [3] | ||
References | |||||
REF 1 | The role of glycogen synthase kinase-3 (GSK-3) in endometrial carcinoma: A carcinogenesis, progression, prognosis, and target therapy marker. Oncotarget. 2016 May 10;7(19):27538-51. | ||||
REF 2 | Methylation-associated silencing of microRNA-129-3p promotes epithelial-mesenchymal transition, invasion and metastasis of hepatocelluar cancer by targeting Aurora-A. Oncotarget. 2016 Nov 22;7(47):78009-78028. | ||||
REF 3 | miR-129-1-3p promote BGC-823 cell proliferation by targeting PDCD2. Anat Rec (Hoboken). 2014 Dec;297(12):2273-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.